Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs directed at increasing the horizons of cytokine-based immunotherapy, especially for cancers where treatment choices remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/bank-of-copyright-joins-ccms-developed-by-tmx-and-clearstream/